GlassScriptPhysician profile
Justin M Vader
NPI 1487864138
$7,605.08
in general payments reported to CMS, 2019-2025
14 companies · $752 in 2025
The $752 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,710 · 2020: $1,156 · 2021: $388 · 2022: $1,189 · 2023: $682 · 2024: $729 · 2025: $752.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,162.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,388.43 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, 2nd Gen Centrimag Primary Console |
| Astrazeneca Pharmaceuticals LP | $1,217.19 | 2020-2022 | |
| Abiomed | $602.74 | 2022-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $270.76 | 2019-2022 | |
| Cvrx, INC. | $230.25 | 2025 | Barostim Neo System |
| Ancora Heart, INC. | $228.99 | 2024 | Accucinch |
| Impulse Dynamics (USA) INC. | $197.04 | 2023-2024 | Optimizer, Optimizer |
| Edwards Lifesciences Corporation | $149.17 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $142.85 | 2023 | Opsumit, Uptravi |
| Medtronic Vascular, INC. | $109.48 | 2019 | |
| Medtronic, INC. | $33.90 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.60 | 2022 | |
| Merck Sharp & Dohme LLC | $12.07 | 2022 | |
| Endotronix, INC. | $9.61 | 2024 | Cordella Pulomonary Artery Pressure Sensor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Vader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.